損益計算書の構造
四半期データ

Bristol-Myers Squibb Co.、連結損益計算書の構成(四半期データ)

3ヶ月終了	2025/03/31	2024/12/31	2024/09/30	2024/06/30	2024/03/31	2023/12/31	2023/09/30	2023/06/30	2023/03/31	2022/12/31	2022/09/30	2022/06/30	2022/03/31	2021/12/31	2021/09/30	2021/06/30	2021/03/31	2020/12/31	2020/09/30	2020/06/30	2020/03/31
純製品売上高	97.19%	95.70%	96.56%	97.74%	97.42%	97.31%	97.07%	97.25%	97.45%	97.01%	96.39%	96.62%	97.08%	96.86%	96.72%	97.45%	97.52%	97.27%	96.75%	96.92%	97.77%
アライアンスおよびその他の収益	2.81%	4.30%	3.44%	2.26%	2.58%	2.69%	2.93%	2.75%	2.55%	2.99%	3.61%	3.38%	2.92%	3.14%	3.28%	2.55%	2.48%	2.73%	3.25%	3.08%	2.23%
収益	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
売上原価は、取得した無形固定資産の償却費を除く	-27.08%	-38.99%	-24.87%	-26.78%	-24.71%	-23.92%	-22.85%	-25.62%	-22.63%	-22.73%	-20.98%	-22.88%	-21.21%	-19.66%	-19.71%	-20.95%	-25.66%	-26.29%	-23.74%	-26.65%	-33.97%
売上総利益率	72.92%	61.01%	75.13%	73.22%	75.29%	76.08%	77.15%	74.38%	77.37%	77.27%	79.02%	77.12%	78.79%	80.34%	80.29%	79.05%	74.34%	73.71%	76.26%	73.35%	66.03%
マーケティング、販売、管理	-14.14%	-17.31%	-16.68%	-15.80%	-19.95%	-18.06%	-18.27%	-17.23%	-15.54%	-19.87%	-17.20%	-15.03%	-15.72%	-19.64%	-15.38%	-16.08%	-15.05%	-24.58%	-16.19%	-16.07%	-14.90%
研究開発	-20.15%	-25.85%	-19.96%	-23.76%	-22.71%	-21.59%	-20.45%	-20.11%	-20.47%	-22.01%	-21.55%	-19.53%	-19.40%	-21.01%	-25.64%	-21.17%	-20.04%	-33.88%	-23.71%	-24.90%	-22.00%
IPRD取得	-1.68%	-0.24%	-2.20%	-1.08%	-109.14%	-5.23%	-0.73%	-1.41%	-0.66%	-0.46%	-0.27%	-3.37%	-2.86%	-0.74%	-2.33%	-6.78%	-0.05%	-103.34%	0.00%	0.00%	0.00%
取得した無形固定資産の償却	-7.41%	-13.72%	-20.23%	-19.80%	-19.87%	-19.85%	-20.57%	-20.11%	-19.90%	-20.54%	-21.55%	-20.33%	-20.75%	-20.17%	-21.90%	-21.76%	-22.69%	-22.82%	-23.63%	-23.59%	-21.17%
営業利益(損失)	29.54%	3.89%	16.06%	12.78%	-96.38%	11.35%	17.13%	15.53%	20.79%	14.40%	18.44%	18.86%	20.05%	18.78%	15.04%	13.25%	16.51%	-110.92%	12.73%	8.80%	7.97%
その他の収入(費用)、純額	-3.02%	-2.47%	-1.97%	-2.24%	-0.68%	3.23%	2.35%	1.03%	3.64%	1.90%	1.25%	-2.39%	-5.57%	-3.28%	3.52%	0.02%	6.34%	16.50%	8.68%	7.27%	-10.79%
税引前利益(損失)	26.52%	1.42%	14.09%	10.54%	-97.06%	14.59%	19.49%	16.56%	24.43%	16.30%	19.69%	16.47%	14.48%	15.50%	18.56%	13.27%	22.85%	-94.43%	21.41%	16.06%	-2.82%
所得税(繰り立て)給付	-4.54%	-0.80%	-3.88%	3.26%	-3.30%	0.77%	-1.85%	1.94%	-4.44%	1.46%	-5.36%	-4.45%	-3.47%	4.29%	-5.20%	-4.20%	-4.52%	3.83%	-3.60%	-16.85%	-4.29%
当期純利益(損失)	21.98%	0.62%	10.22%	13.80%	-100.36%	15.35%	17.64%	18.50%	20.00%	17.75%	14.33%	12.02%	11.01%	19.79%	13.35%	9.07%	18.32%	-90.59%	17.82%	-0.79%	-7.11%
非支配持分	-0.05%	-0.03%	-0.03%	-0.03%	-0.03%	0.00%	-0.05%	-0.04%	-0.04%	-0.03%	-0.02%	-0.07%	-0.04%	0.00%	-0.05%	-0.05%	-0.07%	0.00%	-0.06%	-0.05%	-0.08%
BMSに帰属する当期純利益(損失)	21.93%	0.58%	10.18%	13.77%	-100.39%	15.35%	17.58%	18.47%	19.95%	17.73%	14.32%	11.95%	10.97%	19.79%	13.30%	9.01%	18.25%	-90.59%	17.76%	-0.84%	-7.19%

Bristol-Myers Squibb Co. (NYSE:BMY)

損益計算書の構造 四半期データ

損益計算書の構造
四半期データ